[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
IJRR Information::
For Authors::
For Reviewers::
News & Events::
Web Mail::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Hard Copy 2322-3243
Online 2345-4229
Online Submission
Now you can send your articles to IJRR office using the article submission system.



:: Volume 21, Issue 4 (10-2023) ::
Int J Radiat Res 2023, 21(4): 647-652 Back to browse issues page
Estimation of oesophageal surface dose in breast cancer patients undergoing supraclavicular irradiation by thermoluminescent dosimeter (TLD) and treatment planning system (TPS)
S.S. Mohammed Amin , K.A. Faraj
Department of Anesthesia, College of Health & Medical Technology in Sulaimani, Sulaimani Polytechnic University, Sulaimaniyah, Iraq , Soma.amin@spu.edu.iq
Abstract:   (797 Views)
Background: The purpose of this study was to measure the surface dose in breast cancer patients undergoing supraclavicular irradiation using a thermoluminescent dosimeter (TLD) and compare the measurements to calculated doses determined by the treatment planning system (TPS). The results of in vivo patients’ measurements were verified using a phantom. Materials and Methods: The oesophageal surface dose of 30 breast cancer patients undergoing supraclavicular lymph node irradiation was measured by TLD and TPS. For each patient, two TLDs were positioned on the oesophageal surface. The TLD and TPS results were verified using a phantom that covered from the oesophagus to the supraclavicular area. The TLD was positioned within or outside the treatment field on the phantom depending on the patient. Results: The average oesophagus surface dose was 9.04 ± 5.07 Gy and 8.06 ± 6.17 Gy for TLD and TPS, respectively (p=0.09). Oesophagus surface doses were greater for the left than for the right side. The calculated and measured dose values at the surface for the phantom were 0.78 Gy and 0.96 Gy, respectively, with the TLD placed inside the radiation field (p=0.02). The calculated and measured dose values at the surface for the phantom were 0.024 Gy and 0.10 Gy, respectively, with the TLD placed outside the radiation field (p=0.01). Conclusion: The results showed a good agreement between TLD measurements and TPS calculations, except when the TLD was placed outside the radiation field. Therefore, dose calculations in peripheral regions should be used with caution.
Keywords: Oesophagus, TLD dose, breast cancer, oesophageal dose, TPS dose.
Full-Text [PDF 609 kb]   (414 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
1. 1. Ghoncheh M, Pournamdar Z, Salehiniya H (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev, 17(3): 43-46. [DOI:10.7314/APJCP.2016.17.S3.43] [PMID]
2. Leong SPL, Shen ZZ, Liu TJ, et al. (2013) Is breast cancer the same disease in Asian and Western countries? World J Surg, 34(10): 2308-2324. [DOI:10.1007/s00268-010-0683-1] [PMID] []
3. Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6(5): 391-401. [DOI:10.3816/CBC.2005.n.043] [PMID]
4. Mahshid J and Arbabi F (2005) Cutaneous complication after electron beam therapy in breast cancer. J R Med Sci, 10(6): 368-370.
5. Tobler M and Leavitt DD (1996) Design and production of wax compensators for electron treatments of the chest wall. Med Dosim, 21(4): 199-206. [DOI:10.1016/S0958-3947(96)00126-4]
6. Levitt SH (2006) Technical basis of radiation therapy. Practical clinical applications. 4th ed. Springer, Berlin, Germany.
7. Overgaard M, Jensen MB, Overgaard J, et al. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet, 353(9165): 1641-1648. [DOI:10.1016/S0140-6736(98)09201-0]
8. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J (2006) Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol, 24(15): 2268-2275. [DOI:10.1200/JCO.2005.02.8738] [PMID]
9. Ragaz J, Olivotto IA, Spinelli JJ, et al. (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst, 97(2): 116-126. [DOI:10.1093/jnci/djh297] [PMID]
10. EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935): 2127-2135. [DOI:10.1016/S0140-6736(14)60488-8]
11. Poortmans PM, Collette S, Kirkove C, et al. (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med, 373(4): 317-327. [DOI:10.1056/NEJMoa1415369] [PMID]
12. Whelan TJ, Olivotto IA, Parulekar WR, et al. (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med, 373(4): 307-316. [DOI:10.1056/NEJMoa1415340] [PMID] []
13. Akın M, Ergen A, Unal A, Bese N (2014) Irradiation doses on thyroid gland during the postoperative irradiation for breast cancer. J Cancer Res Ther, 10(4): 942-944. [DOI:10.4103/0973-1482.137991] [PMID]
14. Sethi RA, No HS, Jozsef G, et al. (2012) Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position. Radiother Oncol, 102(1): 74-81. [DOI:10.1016/j.radonc.2011.09.008] [PMID]
15. Richter JE and Castell DO (2011) The Esophagus 6e. Chichester, England: Wiley-Blackwell.
16. Dumane VA, Bakst R, Green S (2018) Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT. PLoS One, 13(10): e0205770. [DOI:10.1371/journal.pone.0205770] [PMID] []
17. Taylor C, Correa C, Duane FK, et al. (2017) Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol, 35(15): 1641-1649. [DOI:10.1200/JCO.2016.72.0722] [PMID] []
18. Darby SC, Ewertz M, McGale P, et al. (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 368(11): 987-998. [DOI:10.1056/NEJMoa1209825] [PMID]
19. Journy N, Schonfeld SJ, Hauptmann M, et al. (2020) Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. Radiother Oncol, 151: 33-39. [DOI:10.1016/j.radonc.2020.07.022] [PMID]
20. Duane FK, Kerr A, Wang Z, et al. (2021) Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020. Radiother Oncol, 164: 261-7. [DOI:10.1016/j.radonc.2021.09.032] [PMID]
21. Clarke M, Collins R, Darby S, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 366(9503): 2087-2106. [DOI:10.1016/S0140-6736(05)67887-7] [PMID]
22. Sharma DS, Animesh, Deshpande SS, et al. (2006) Peripheral dose from uniform dynamic multileaf collimation fields: implications for sliding window intensity-modulated radiotherapy. Br J Radiol, 79(940): 331-335. [DOI:10.1259/bjr/16208090] [PMID]
23. Herbert CE, Ebert MA, Joseph DJ (2003) Feasible measurement errors when undertaking in vivo dosimetry during external beam radiotherapy of the breast. Med Dosim, 28(1): 45-48. [DOI:10.1016/S0958-3947(02)00241-8]
24. Siji CT, Musthafa MM, Ganapathi RR, et al. (2015) Out-of-field photon dosimetry study between 3-D conformal and intensity modulated radiation therapy in the management of prostate cancer. Int J Radiat Res, 13(2): 127-134.
25. Akpochafor MO, Adeneye SO, Habeebu MY, et al. (2019) Organ dose measurement in computed tomography using thermoluminescence dosimeter in locally developed phantoms. Iran J Med Phys, 16(2): 126-132.
26. Huang JY, Followill DS, Wang XA, Kry SF (2013) Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments. J Appl Clin Med Phys, 14(2): 186-197. [DOI:10.1120/jacmp.v14i2.4139] [PMID] []
27. West K, Schneider M, Wright C, et al. (2020) Radiation-induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation. J Med Imaging Radiat Oncol, 64(1): 113-119. [DOI:10.1111/1754-9485.12943] [PMID]
28. Lonski P, Kron T, Taylor M, et al. (2018) Assessment of leakage dose in vivo in patients undergoing radiotherapy for breast cancer. Phys Imaging Radiat Oncol, 5: 97-101. [DOI:10.1016/j.phro.2018.03.004] [PMID] []
29. Nikoofar A, Hoseinpour Z, Rabi Mahdavi S, et al. (2015) High-dose-rate (192)Ir brachytherapy dose verification: A phantom study. Iran J Cancer Prev, 8(3): e2330. [DOI:10.17795/ijcp2330]
30. Taylor ML and Kron T (2011) Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy. J Med Phys, 36(2): 59-71. [DOI:10.4103/0971-6203.79686] [PMID] []
31. Lonski P, Taylor ML, Hackworth W, et al. (2014) In-vivo verification of radiation dose delivered to healthy tissue during radiotherapy for breast cancer. Journal of Physics, 489(1): 012015. [DOI:10.1088/1742-6596/489/1/012015]
32. Soleymanifard S, Aledavood SA, Noghreiyan AV, et al. (2016) In vivo skin dose measurement in breast conformal radiotherapy. Contemp Oncol (Pozn), 20(2): 137-140. [DOI:10.5114/wo.2015.54396] [PMID] []
33. Abdemanafi M, Tavakoli MB, Akhavan A, Abedi I (2020) Evaluation of the lung dose in three-dimensional conformal radiation therapy of left-sided breast cancer: A phantom study. J Med Signals Sens, 10(1): 48-52. [DOI:10.4103/jmss.JMSS_1_19] [PMID] []
34. Davidson SE, Ibbott GS, Prado KL, et al. (2007) Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom: Heterogeneity dose calculation algorithms accuracy using anthropomorphic phantom. Med Phys, 34(5): 1850-1857. [DOI:10.1118/1.2727789] [PMID]
35. Howell RM, Scarboro SB, Kry SF, Yaldo DZ (2010) Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol, 55(23): 6999-7008. [DOI:10.1088/0031-9155/55/23/S03] [PMID] []
36. Kowalik A, Konstanty E, Piotrowski T, et al. (2019) Calculation and measurement of doses in the surface layers of a phantom when using Tomotherapy. Rep Pract Oncol Radiother, 24(2): 251-262. [DOI:10.1016/j.rpor.2018.11.006] [PMID] []
37. Kaderka R, Schardt D, Durante M, et al. (2012) Out-of-field dose measurements in a water phantom using different radiotherapy modalities. Phys Med Biol, 57(16): 5059-5074. [DOI:10.1088/0031-9155/57/16/5059] [PMID]
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammed Amin S, Faraj K. Estimation of oesophageal surface dose in breast cancer patients undergoing supraclavicular irradiation by thermoluminescent dosimeter (TLD) and treatment planning system (TPS). Int J Radiat Res 2023; 21 (4) :647-652
URL: http://ijrr.com/article-1-5020-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 4 (10-2023) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.06 seconds with 50 queries by YEKTAWEB 4642